Jama Pitman Net Worth & Insider Trades

Jama Pitman - See Remarks, Deciphera Pharmaceuticals, Inc

As of June 21, 2022

What is Jama Pitman's Net Worth?

The current estimated net worth of Deciphera Pharmaceuticals, Inc's See Remarks, Jama Pitman, is estimated to be about $328.56K . Jama Pitman owns about 36,661 units of Deciphera Pharmaceuticals, Inc common stock. In the last year at Deciphera Pharmaceuticals, Inc, Jama Pitman has sold an estimated value of $24.32K worth.

What is Jama Pitman's Past Insider Trading?

Jama Pitman's largest sale order was 1,298 units , worth over $13.95K on June 21, 2022. In total, Jama Pitman has made about 4 transactions over a year of their time at Deciphera Pharmaceuticals, Inc. Jama Pitman usually trades in June, January, February and December, with the busiest year in 2022.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Jama Pitman's' Mailing Address?

  • Mailing address is C/o Deciphera Pharmaceuticals, Inc. 200 Smith Street Waltham MA 02451 MA

Deciphera Pharmaceuticals, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Steven L. Hoerter 2020 $650,000 - - $6,597,306 $536,250 $11,388 $7,794,944
Steven L. Hoerter 2019 $449,886 - $1,320,800 $6,776,000 $478,500 - $9,025,186
Thomas P. Kelly 2020 $447,200 - $386,285 $1,546,335 $272,278 $7,386 $2,659,484
Thomas P. Kelly 2019 $430,000 - - $1,308,788 $336,690 $11,200 $2,086,678
Thomas P. Kelly 2018 $370,000 - - $1,755,252 $175,000 $11,000 $2,311,252
Matthew L. Sherman, M.D. 2020 $504,986 - $96,571 $385,576 $307,461 $5,962 $1,300,556
Matthew L. Sherman, M.D. 2019 $125,000 $150,000 $1,205,050 $3,458,715 $84,593 $115,164 $5,138,522
Daniel L. Flynn, Ph.D. 2020 $442,000 - $386,285 $1,546,335 $269,112 $11,400 $2,655,132
Daniel C. Martin 2020 $436,800 - $386,285 $1,546,335 $247,141 $23,882 $2,640,443
Daniel C. Martin 2019 $420,000 - - $907,426 $253,344 $505,549 $2,086,319
Daniel C. Martin 2018 $117,875 $100,000 $722,000 $2,189,097 $45,000 $702 $3,174,674
Stephen B. Ruddy, Ph.D. 2020 $383,400 - $386,285 $1,546,335 $216,928 $1,212 $2,534,160
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1654151/000165415121000007/dcph-2021xproxystatement.htm

What are Deciphera Pharmaceuticals, Inc's Past Insider Trades?

Deciphera Pharmaceuticals, Inc's most recent insider trade came on October 5, 2022 by Matthew Sherman who sold 2,587 units worth $48.45K . In the last 5 years, insiders at Deciphera Pharmaceuticals, Inc have sold an estimated value of $102.45M and bought an estimated value of $33.3M worth of shares. Insider trading is most common in June, with the busiest year in 2020. The most active traders at the company are Douglas Michael Taylor, Director,  Patrick Thomas Kelly, Chief Financial Officer,  and Arthur James Bristol, Director .

Deciphera Pharmaceuticals, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1